Lasting Effect Consumer Pharma · raw details

Lasting Effect develops pharmaceutical therapeutics based on a proprietary buccal extended-release drug delivery system. The company’s technology utilizes adhesive tablets designed to attach to the oral mucosa, enabling the continuous administration of active ingredients either topically or systemically while bypassing the digestive tract. This approach effectively addresses challenges such as swallowing difficulties (dysphagia) and administration compliance often associated with traditional oral or invasive delivery methods. Key applications of the platform include saliva-stimulating treatments for dry mouth (xerostomia) and anti-bacterial formulations for gingivitis. Additionally, the company offers a non-invasive solution for late-stage Parkinson’s disease, providing prolonged dopamine secretion as an alternative to continuous infusion pumps. By ensuring sustained drug release, the solution maintains consistent therapeutic levels and enhances patient care for chronic conditions.